Marvel Us Disney Episode 119: Channing Tatum's MCU Hiatus, Spider-Man: No Way Home Box Office, and Willem Dafoe's Teeth
Jim Hill MediaOctober 27, 202547 min85 views
30 connectionsΒ·40 entities in this videoβChanning Tatum's MCU Embargo
- π¬ Channing Tatum has stated he can no longer watch Marvel movies following the cancellation of the Gambit movie.
- β οΈ He is unaware of recent MCU films like "Spider-Man: Far From Home" and "The Eternals," as well as Disney+ shows like "Hawkeye" and "Loki."
- π Listeners are advised not to discuss Marvel content with Tatum until he is cast as a Marvel hero again.
Spider-Man: No Way Home Box Office Success
- π "Spider-Man: No Way Home" continues to dominate the box office, marking its seventh weekend at number one.
- π° The film has surpassed $735.9 million domestically, nearing James Cameron's "Avatar" domestic gross.
- π Internationally, "No Way Home" has crossed the $1 billion mark, notably without a release in China due to foreign film quotas.
- π₯ The film's worldwide box office total stands at $1.73 billion.
Willem Dafoe's Green Goblin Teeth
- π‘ A fascinating detail about Willem Dafoe's portrayal of Norman Osborn/Green Goblin is revealed: he used fake teeth for his Norman smile and his own teeth for the Green Goblin persona.
- π¦· Dafoe's natural canines are slightly longer, giving the Green Goblin a more menacing, almost vampire-like appearance.
- π This subtle physical transformation contributed to the creepiness of the Green Goblin's smile in both the 2002 "Spider-Man" and "Spider-Man: No Way Home."
Spider-Man 4 and Tom Holland's Contract
- π€ Tom Holland stated that discussions for "Spider-Man 4" are tentative, with Sony and Marvel Studios far from deciding on the film's direction.
- πΈοΈ Rumors of team-ups with Tobey Maguire, Andrew Garfield, or Miles Morales have been downplayed by Holland.
- πΌ Holland's contract with Sony reportedly ended with "No Way Home," creating a negotiation point for future films.
- π€ The power dynamic between Sony, Marvel, and Holland is discussed, with Sony funding the film and Marvel contributing 25%.
- π¬ The release of Holland's film "Uncharted" could impact his leverage in negotiations for "Spider-Man 4."
- β A key narrative challenge for "Spider-Man 4" is how Peter Parker can return when his identity was erased at the end of "No Way Home."
Marvel Actors and Controversies
- π£οΈ Evangeline Lilly faced criticism for her comments on bodily sovereignty and vaccine mandates, which some deemed irresponsible.
- π° Simu Liu also commented on the media spotlighting opinions not rooted in facts or science, referencing his own experience and loss due to COVID-19.
- π¬ The handling of actor controversies, like Lilly's and Letitia Wright's alleged sharing of anti-vaccine content, poses a challenge for Marvel and Disney, particularly with upcoming films like "Black Panther: Wakanda Forever."
Loki Season 2 and Kang the Conqueror
- β³ "Loki" Season 2 is confirmed to begin shooting in London this summer, with a potential release in Spring 2023.
- π The season may lead directly into "Ant-Man and the Wasp: Quantumania," potentially featuring Jonathan Majors as Kang the Conqueror.
- π₯ This suggests a more integrated rollout for Kang as the MCU's next major villain, with character development potentially starting in "Loki."
- β The possibility of "Loki" Season 2 being used to further develop Kang before his "Ant-Man" appearance is explored.
Knowledge graph40 entities Β· 30 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover Β· drag to explore
40 entities
Chapters3 moments
Key Moments
Transcript176 segments
Full Transcript
Topics15 themes
Whatβs Discussed
Spider-Man: No Way HomeMarvel Cinematic UniverseWillem DafoeGreen GoblinChanning TatumGambitSpider-Man 4Tom HollandSony PicturesMarvel StudiosLoki Season 2Kang the ConquerorJonathan MajorsEvangeline LillyLetitia Wright
Smart Objects40 Β· 30 links
CompaniesΒ· 5
PeopleΒ· 19
MediasΒ· 12
ConceptsΒ· 2
EventsΒ· 2